Top News

U.S. government commits $1.6B to Novavax, Regeneron is in Phase 3 for COVID-19 treatment

As confirmed cases of COVID-19 continue to surge across the United States, the U.S. government committed $1.6 billion dollars to Novavax for a vaccine. Yahoo Finance’s Emily McCormick and Yahoo Medical Contributor Dr. Dara Kass join The First Trade to discuss that and much more.

View Article Origin Here

Related Articles

Back to top button